The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015
Fig 1
Age-specific prevalence of anti-HAV, persons aged ≥10 years, KNHANES 2015.
(A) Included in the national immunization recommendation of hepatitis A vaccine (B) Not included. In South Korea, the HAV vaccine for the children aged 12–26 months started in 1997 as one of the National Childhood Vaccine Program. Children aged 10–19 years in 2015 were recommended for HAV vaccine, but aged 20 years and over were not recommended.